[HTML][HTML] Glucagon-like peptide-1 secretion in people with versus without type 2 diabetes: a systematic review and meta-analysis of cross-sectional studies
Abstract Aims/Hypothesis The aim of this systematic review was to synthesise the study
findings on whether GLP-1 secretion in response to a meal tolerance test is affected by the …
findings on whether GLP-1 secretion in response to a meal tolerance test is affected by the …
Circulating levels of all proglucagon-derived peptides are differentially regulated postprandially by obesity status and in response to high-fat meals vs. high …
K Stefanakis, A Kokkinos, S Simati, G Argyrakopoulou… - Clinical Nutrition, 2023 - Elsevier
Background & aims We measured all proglucagon-derived peptides (PGDPs) levels in
response to administration of three mixed meal tolerance tests (MMTs), examining …
response to administration of three mixed meal tolerance tests (MMTs), examining …
Circulating levels of five proglucagon-derived peptides in response to intravenous or oral glucose or lipids and to a mixed-meal in subjects with normal weight …
Summary Aims Proglucagon-derived peptides (PGDPs) secreted by the gut and pancreas
play a major role in metabolism. We measured concentrations of five PGDPs in response to …
play a major role in metabolism. We measured concentrations of five PGDPs in response to …
Circulating levels of proglucagon‐derived peptides are differentially regulated by the glucagon‐like peptide‐1 agonist liraglutide and the centrally acting naltrexone …
K Stefanakis, A Kokkinos… - Diabetes, Obesity …, 2023 - Wiley Online Library
Aim To investigate the changes of circulating levels of all proglucagon‐derived peptides
(PGDPs) in individuals with overweight or obesity receiving liraglutide (3 mg) or …
(PGDPs) in individuals with overweight or obesity receiving liraglutide (3 mg) or …
[HTML][HTML] Response to lowering plasma glucose is characterised by decreased oxyntomodulin: Results from a randomised controlled trial
Y Liu, W Kimita, SH Bharmal, MS Petrov - Diabetes & Metabolic Syndrome …, 2024 - Elsevier
Background With the prevalence of diabetes reaching an epidemic level, there is a growing
interest in the investigation of its remission. Proglucagon-derived peptides (PGDP) have …
interest in the investigation of its remission. Proglucagon-derived peptides (PGDP) have …
[HTML][HTML] Post-prandial secretion of glucagon-like peptide-2 (GLP-2) after carbohydrate-, fat-or protein enriched meals in healthy subjects
AP Prahm, MK Hvistendahl, CF Brandt, P Blanche… - Peptides, 2023 - Elsevier
Abstract Glucagon-like peptide 2 (GLP-2) is an important regulator of intestinal growth and
function. In adherable mixed meals the macronutrient composition with the best potential for …
function. In adherable mixed meals the macronutrient composition with the best potential for …
Effects of ileal glucose infusion on enteropancreatic hormone secretion in humans: relationship to glucose absorption
Backgrounds The distal small intestine plays an important role in regulating the secretion of
entero-pancreatic hormones that are critical to the control of glucose metabolism and …
entero-pancreatic hormones that are critical to the control of glucose metabolism and …
Circulating levels of gastrointestinal hormones in prediabetes reversing to normoglycemia or progressing to diabetes in a year–A cross-sectional and prospective …
C Hoffmann, PE Schwarz, CS Mantzoros… - Diabetes Research and …, 2023 - Elsevier
Aims We aimed to compare the concentrations of GLP-1, glucagon and GIP (established
regulators of glucose homeostasis) and glicentin (emerging new metabolic marker) during …
regulators of glucose homeostasis) and glicentin (emerging new metabolic marker) during …
Bariatric surgery, through beneficial effects on underlying mechanisms, improves cardiorenal and liver metabolic risk over an average of ten years of observation: A …
Background Bariatric surgery has long-term beneficial effects on body weight and metabolic
status, but there is an apparent lack of comprehensive cardiometabolic, renal, liver, and …
status, but there is an apparent lack of comprehensive cardiometabolic, renal, liver, and …